デフォルト表紙
市場調査レポート
商品コード
1631239

生体インピーダンス分光法の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測(2032年)

Bioimpedance Spectroscopy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032


出版日
ページ情報
英文 185 Pages
納期
2~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
生体インピーダンス分光法の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測(2032年)
出版日: 2025年01月07日
発行: Fairfield Market Research
ページ情報: 英文 185 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生体インピーダンス分光法(BIS)市場は、ヘルスケアが非侵襲的診断と個別化医療にシフトする中、変革的な成長を遂げています。BISは周波数にわたって生体組織のインピーダンスを測定し、体液の分布や組織の組成に関する知見を提供します。BISの市場規模はCAGR12.70%で成長し、2025年の5億7,000万米ドルから2032年には13億1,980万米ドルになると予測されています。

BIS市場はCAGR12.70%を達成すると予測され、ヘルスケアおよび消費者ウェルネス分野での採用拡大が大幅な成長を牽引するとみられます。BIS技術の需要は、精密医療と予防医療に向けた世界の動向を浮き彫りにしています。

生体インピーダンス分光法市場は、ヘルスケアや消費者向け用途への統合が進むにつれて、継続的な成長が見込まれます。研究開発、ウェアラブル技術開発、世界の協力体制への戦略的投資は、現在の課題に対処し、BISの可能性を最大限に引き出すために極めて重要です。非侵襲的な診断への需要が高まる中、BISは精密医療と予防医療の未来を形作る上で重要な役割を果たすことになるとみられています。

心血管疾患やがんの有病率の上昇は、BISのような高度な診断ツールに対する需要を強調しています。早期かつ正確な診断が可能なBISは、慢性疾患の管理に不可欠なソリューションです。ヘルスケアシステムが予防医療を重視する中、非侵襲的でリアルタイムのモニタリングツールが不可欠となっています。BISのリアルタイムで実用的な洞察を提供する能力は、その普及を支えています。BISは、高度な体組成分析および水分補給モニタリングのために、アスリートやフィットネス愛好家別ますます使用されるようになっており、カスタマイズされたフィットネス計画とパフォーマンスの向上を可能にしています。小型化の革新とウェアラブル機器へのBISの統合により、ポイント・オブ・ケア・アプリケーションの新たな機会が開かれ、診断がより身近で効率的になります。

当レポートでは、世界の生体インピーダンス分光法市場について調査し、市場の概要とともに、製品別、モダリティ別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 2024年の価格分析

第4章 世界の生体インピーダンス分光法市場の見通し、2019年~2032年

  • 世界の生体インピーダンス分光法市場の見通し、製品別、金額(10億米ドル)、数量(件)、2019年~2032年
  • 世界の生体インピーダンス分光法市場の見通し、モダリティ別、金額(10億米ドル、2019年~2032年)
  • 世界の生体インピーダンス分光法市場の見通し、エンドユーザー別、金額(10億米ドル、2019年~2032年)
  • 世界の生体インピーダンス分光法市場の見通し、地域別、金額(10億米ドル)、数量(件)、2019年~2032年

第5章 北米の生体インピーダンス分光法市場の見通し、2019年~2032年

第6章 欧州の生体インピーダンス分光法市場の見通し、2019年~2032年

第7章 アジア太平洋の生体インピーダンス分光法市場の見通し、2019年~2032年

第8章 ラテンアメリカの生体インピーダンス分光法市場の見通し、2019年~2032年

第9章 中東・アフリカの生体インピーダンス分光法市場の見通し、2019年~2032年

第10章 競合情勢

  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Tanita Corporation
    • Akern
    • Biodynamics Corporation
    • Bioparhom
    • Biotekna
    • Bodystat Ltd
    • Charder Electronic Co. Ltd
    • Evolt 360
    • Fook Tin Group Holding Ltd
    • InBody Co. Ltd
    • Lumsail Industrial Inc.
    • Maltron International
    • Omron Corporation
    • RJL Systems
    • Seca GmbH & Co. KG

第11章 付録

目次

The Bioimpedance Spectroscopy (BIS) market is undergoing transformative growth as healthcare shifts towards non-invasive diagnostics and personalized medicine. BIS measures biological tissue impedance across frequencies, offering insights into fluid distribution and tissue composition. Applications span from chronic disease management to sports medicine, making BIS a cornerstone in modern healthcare.The BIS market is forecasted to grow at a compound annual growth rate (CAGR) of 12.70%, with an estimated market value of USD 570 million by 2025 and USD 1,319.8 million by 2032.

Market Overview

The BIS market is projected to achieve a compound annual growth rate (CAGR) of 12.70%, with substantial growth driven by increasing adoption in healthcare and consumer wellness sectors. The demand for BIS technologies highlights the global trend toward precision and preventive medicine.

The bioimpedance spectroscopy market is poised for continued growth as it integrates into broader healthcare and consumer applications. Strategic investments in R&D, wearable technology development, and global collaborations are pivotal to addressing current challenges and unlocking the full potential of BIS. With increasing demand for non-invasive diagnostics, BIS is set to play a vital role in shaping the future of precision and preventive healthcare.

Key Drivers

  • Chronic Disease Management: The rising prevalence of cardiovascular diseases and cancer underscores the demand for advanced diagnostic tools like BIS. Its ability to provide early and precise diagnostics positions it as a critical solution in managing chronic diseases.
  • Preventive Healthcare: As healthcare systems emphasize preventive care, non-invasive and real-time monitoring tools are becoming essential. BIS's ability to deliver actionable insights in real-time supports its widespread adoption.
  • Fitness and Sports Applications: BIS is increasingly being used by athletes and fitness enthusiasts for advanced body composition analysis and hydration monitoring, enabling customized fitness plans and improved performance.
  • Technological Advancements: Innovations in miniaturization and the integration of BIS in wearable devices open new opportunities for point-of-care applications, making diagnostics more accessible and efficient.

Opportunities

  • Expanding Clinical Applications: Beyond traditional areas like oncology and lymphedema management, BIS shows potential in neurology, nephrology, and metabolic disorders. These expanding applications offer significant revenue opportunities for market players.
  • Wearable Technology Integration: Embedding BIS sensors in fitness trackers and smartwatches creates new possibilities for real-time health monitoring, appealing to both consumers and healthcare providers.
  • Strategic Collaborations: Partnerships between BIS manufacturers, healthcare institutions, and research organizations can drive innovation and broaden the scope of BIS applications.

Challenges

  • Regulatory Barriers: The diverse regulatory Analysis across regions poses challenges for BIS device manufacturers. Ensuring compliance with global standards demands significant investments in research and development.
  • Integration Issues: Seamless integration of BIS technologies into existing healthcare systems, particularly electronic health records, remains a challenge that requires technological refinement.
  • Technological Constraints: While BIS devices are evolving, achieving consistent precision, scalability, and cost-efficiency remains crucial for long-term market growth.

Regional Insights

  • Europe: Europe leads the BIS market due to its robust healthcare infrastructure and supportive policies. High adoption rates for innovative healthcare technologies position the region as a dominant force in the market.
  • South Asia & Pacific: This region represents the fastest-growing segment in the BIS market. Increasing healthcare awareness and investments in medical technologies are driving adoption, particularly in emerging economies.
  • North America: Advanced healthcare systems and significant investments in R&D place North America as a pivotal region for BIS market expansion.

Recent Innovations

  • 1. Samsung Galaxy Watch: This wearable device includes BIS assessment capabilities, offering consumers a convenient and precise tool for health monitoring.
  • 2. Withings Body Scan Scale: With features like multi-frequency BIS, ECG, and heart rate monitoring, this innovation enhances personalized health diagnostics for consumers.

Leading Companies

Key players in the BIS market include:

  • Tanita Corporation
  • Akern
  • Biodynamics Corporation
  • Samsung
  • Withings
  • ImpediMed Ltd.
  • Omron Corporation

These companies are focusing on innovation, strategic partnerships, and customer-centric solutions to strengthen their market presence.

Market Segmentation

  • By Product: Single Frequency BIS Multiple Frequency BIS
  • By Modality: Hand-held BIA Hand-to-Foot BIA Leg-to-Leg BIA
  • By End User: Hospitals Specialty Clinics Ambulatory Surgical Centers (ASCs) Rehabilitation Centers
  • By Region: North America Europe Asia-Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bioimpedance Spectroscopy Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume (Units), 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2024

  • 3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Bioimpedance Spectroscopy Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 4.1. Global Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Single Frequency
      • 4.1.1.2. Multiple Frequency
  • 4.2. Global Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hand-held BIA
      • 4.2.1.2. Hand-to-Foot BIA
      • 4.2.1.3. Leg-to-Leg BIA
  • 4.3. Global Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialty Clinics
      • 4.3.1.3. Ambulatory Surgical Centers
      • 4.3.1.4. Rehabilitation Center
  • 4.4. Global Bioimpedance Spectroscopy Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 5.1. North America Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Single Frequency
      • 5.1.1.2. Multiple Frequency
  • 5.2. North America Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hand-held BIA
      • 5.2.1.2. Hand-to-Foot BIA
      • 5.2.1.3. Leg-to-Leg BIA
  • 5.3. North America Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialty Clinics
      • 5.3.1.3. Ambulatory Surgical Centers
      • 5.3.1.4. Rehabilitation Center
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. North America Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.2. U.S. Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. U.S. Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. Canada Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.5. Canada Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. Canada Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 6.1. Europe Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Single Frequency
      • 6.1.1.2. Multiple Frequency
  • 6.2. Europe Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hand-held BIA
      • 6.2.1.2. Hand-to-Foot BIA
      • 6.2.1.3. Leg-to-Leg BIA
  • 6.3. Europe Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialty Clinics
      • 6.3.1.3. Ambulatory Surgical Centers
      • 6.3.1.4. Rehabilitation Center
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Europe Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.2. Germany Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. Germany Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. U.K. Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.5. U.K. Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. U.K. Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. France Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.8. France Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. France Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. Italy Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.11. Italy Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. Italy Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Turkey Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.14. Turkey Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Turkey Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Russia Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.17. Russia Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Russia Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.19. Rest of Europe Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.20. Rest of Europe Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.21. Rest of Europe Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Single Frequency
      • 7.1.1.2. Multiple Frequency
  • 7.2. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Hand-held BIA
      • 7.2.1.2. Hand-to-Foot BIA
      • 7.2.1.3. Leg-to-Leg BIA
  • 7.3. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialty Clinics
      • 7.3.1.3. Ambulatory Surgical Centers
      • 7.3.1.4. Rehabilitation Center
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.2. China Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. China Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Japan Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.5. Japan Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Japan Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. South Korea Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.8. South Korea Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. South Korea Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. India Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.11. India Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. India Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.13. Southeast Asia Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.14. Southeast Asia Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.15. Southeast Asia Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.16. Rest of Asia Pacific Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.17. Rest of Asia Pacific Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.18. Rest of Asia Pacific Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 8.1. Latin America Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Single Frequency
      • 8.1.1.2. Multiple Frequency
  • 8.2. Latin America Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hand-held BIA
      • 8.2.1.2. Hand-to-Foot BIA
      • 8.2.1.3. Leg-to-Leg BIA
  • 8.3. Latin America Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialty Clinics
      • 8.3.1.3. Ambulatory Surgical Centers
      • 8.3.1.4. Rehabilitation Center
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Latin America Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.2. Brazil Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. Brazil Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. Mexico Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.5. Mexico Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. Mexico Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Argentina Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.8. Argentina Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Argentina Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Rest of Latin America Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.11. Rest of Latin America Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Rest of Latin Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Single Frequency
      • 9.1.1.2. Multiple Frequency
  • 9.2. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Hand-held BIA
      • 9.2.1.2. Hand-to-Foot BIA
      • 9.2.1.3. Leg-to-Leg BIA
  • 9.3. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Specialty Clinics
      • 9.3.1.3. Ambulatory Surgical Centers
      • 9.3.1.4. Rehabilitation Center
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.2. GCC Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.3. GCC Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.4. South Africa Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.5. South Africa Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.6. South Africa Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.7. Egypt Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.8. Egypt Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.9. Egypt Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.10. Nigeria Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.11. Nigeria Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.12. Nigeria Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.13. Rest of Middle East & Africa Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.14. Rest of Middle East & Africa Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.15. Rest of Middle East & Africa Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. Tanita Corporation
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Product Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Akern
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Product Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Biodynamics Corporation
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Product Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. Bioparhom
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Product Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Biotekna
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Product Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Bodystat Ltd
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Product Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. Charder Electronic Co. Ltd
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Product Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Evolt 360
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Product Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. Fook Tin Group Holding Ltd
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Product Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. InBody Co. Ltd
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Product Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Lumsail Industrial Inc.
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Product Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. Maltron International
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Product Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development
    • 10.3.13. Omron Corporation
      • 10.3.13.1. Company Overview
      • 10.3.13.2. Product Portfolio
      • 10.3.13.3. Financial Overview
      • 10.3.13.4. Business Strategies and Development
    • 10.3.14. RJL Systems
      • 10.3.14.1. Company Overview
      • 10.3.14.2. Product Portfolio
      • 10.3.14.3. Financial Overview
      • 10.3.14.4. Business Strategies and Development
    • 10.3.15. Seca GmbH & Co. KG
      • 10.3.15.1. Company Overview
      • 10.3.15.2. Product Portfolio
      • 10.3.15.3. Financial Overview
      • 10.3.15.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations